Vote to Help Award a $21,000 AbbVie CF Scholarship to Two Inspirational
Students with Cystic Fibrosis Pursuing their Goals of Higher Education
NORTH CHICAGO, Ill., Aug. 19, 2013
NORTH CHICAGO, Ill., Aug. 19, 2013 /PRNewswire/ --AbbVie has selected 40
exceptional undergraduate and graduate students living with cystic fibrosis
(CF) to each receive a $2,500 AbbVie CF Scholarship for the 2013-2014 school
year based on their academic excellence, extracurricular activities and
creativity. The AbbVie CF Scholars are now competing for two additional
scholarships for a total award of $21,000 each and the title of 2013 Thriving
Undergraduate or Graduate Student. From now until Monday, Sept. 16, 2013,
please vote at www.AbbVieCFScholarship.com for two outstanding and
Cystic fibrosis is an inherited chronic disease that affects the lungs and
digestive systems of approximately 30,000 children and adults in the United
States. Today, more than 45 percent of people living with CF are aged 18 or
"We continue to be impressed with the caliber of the AbbVie CF Scholarship
applicants. These students have achieved tremendous personal and academic
success, while living with cystic fibrosis, a physically and emotionally
challenging disease," said Jim Hynd, vice president, Endo-Metabolic, and GI
Care, AbbVie. "AbbVie is pleased to celebrate the unique achievements of
these remarkable students and support their educational endeavors."
The AbbVie CF Scholarship website, www.AbbVieCFScholarship.com, showcases the
motivating stories and extraordinary accomplishments of this year's scholars
and instructions on how to vote. The public is encouraged to cast its vote for
a favorite undergraduate and graduate student online at
www.AbbVieCFScholarship.com and via text message. To place a vote via text
message, text 23000 with the unique ID provided online for the specific
scholar (e.g., VOTE1, VOTE2, etc.). AbbVie will announce the 2013 Thriving
Undergraduate and Graduate Student winners in October.
More than 500 students with CF have received an estimated $2.4 million in
educational funding throughout the 21-year legacy of the scholarship program.
It was not necessary for scholarship applicants to have taken, currently take,
or intend to take in the future, any medicine or product marketed by AbbVie
and this was not a consideration in the selection criteria.
"The AbbVie CF Scholarship provided me with needed financial support to help
achieve my educational goals and follow my passion for biology," said 2012
Thriving Graduate Student, Wesley McSparin. "It's really great to see that the
program continues to offer a new class of scholars the opportunity to pursue
their educational aspirations, and I look forward to voting for a Thriving
Undergraduate and Graduate Student."
About Cystic Fibrosis
In patients with CF, a thick, sticky mucus is produced in certain organs
throughout the body, most commonly the lungs and digestive system. The mucus
build-up in the lungs can cause difficulty breathing and may lead to
life-threatening lung infections. In the digestive system, the thick mucus may
prevent proper food digestion. More than 70 percent of people with CF are
diagnosed by age two.
AbbVie is a global, research-based biopharmaceutical company formed in 2013
following separation from Abbott. The company's mission is to use its
expertise, dedicated people and unique approach to innovation to develop and
market advanced therapies that address some of the world's most complex and
serious diseases. In 2013, AbbVie employs approximately 21,000 people
worldwide and markets medicines in more than 170 countries. For further
information on the company and its people, portfolio and commitments, please
visit www.abbvie.com. Follow @abbvie on Twitter or view careers on our
Facebookor LinkedIn page.
Contact: Phyliss Milligan, +1-847-937-6477
Press spacebar to pause and continue. Press esc to stop.